GLP-1RA initiation linked to new thyroid cancer diagnoses

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor agonists.

Study identifies hormonal and reproductive factors for rheumatoid arthritis in women

Early menopause-;before the age of 45-;taking hormone replacement therapy (HRT), and having 4 or more children are among several hormonal and reproductive factors linked to

January 10, 2024

SGLT2 Inhibitor Carry-Over Benefits Last How Long?

SAN DIEGO — Benefits with empagliflozin (Jardiance) for cardiovascular and renal health linger for about a year after discontinuation, as off-drug follow-up from the EMPA-KIDNEY

October 30, 2024

FDA’s Peter Marks seems inclined to grant full approval to Sarepta’s Duchenne gene therapy

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.